Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

A Healthy Lifestyle Index in Relation to Risk of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Arthur R, Brasky TM, Crane TE, Felix AS, Kaunitz A, Shadyab AH, Qi L, Wassertheil-Smoller S, Rohan TE.

Am J Epidemiol. 2018 Nov 8. doi: 10.1093/aje/kwy249. [Epub ahead of print]

PMID:
30407487
2.

Pulmonary Artery Compression and Invasion by a Ruptured Giant Thoracic Aortic Aneurysm: A Rare Presentation.

Felix AS, Alves LA, Felipe AR, Costa ALC, Segalote RC, Zappa MB, Camargo GC.

CASE (Phila). 2018 May 4;2(5):201-206. doi: 10.1016/j.case.2018.02.005. eCollection 2018 Oct. No abstract available.

3.

Cancer Progress and Priorities: Uterine Cancer.

Felix AS, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):985-994. doi: 10.1158/1055-9965.EPI-18-0264. No abstract available.

PMID:
30181320
4.

Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA.

Am J Obstet Gynecol. 2018 Nov;219(5):459.e1-459.e11. doi: 10.1016/j.ajog.2018.08.002. Epub 2018 Aug 7.

PMID:
30096321
5.

Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival.

Felix AS, Sinnott JA, Vetter MH, Rhoades J, Cohn DE, Backes FJ, Sherman ME, Suarez AA.

Gynecol Oncol. 2018 Jul;150(1):38-43. doi: 10.1016/j.ygyno.2018.05.005. Epub 2018 May 10.

PMID:
29754740
6.

Life after endometrial cancer: A systematic review of patient-reported outcomes.

Shisler R, Sinnott JA, Wang V, Hebert C, Salani R, Felix AS.

Gynecol Oncol. 2018 Feb;148(2):403-413. doi: 10.1016/j.ygyno.2017.11.007. Epub 2017 Nov 14. Review.

PMID:
29150143
7.

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA.

Int J Cancer. 2018 Mar 15;142(6):1102-1115. doi: 10.1002/ijc.31127. Epub 2017 Nov 6.

PMID:
29063589
8.

Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency.

Li Z, Joehlin-Price AS, Rhoades J, Ayoola-Adeola M, Miller K, Parwani AV, Backes FJ, Felix AS, Suarez AA.

Int J Gynecol Cancer. 2018 Jan;28(1):59-68. doi: 10.1097/IGC.0000000000001120.

PMID:
29053481
9.

Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.

Felix AS, Lehman A, Foraker RE, Naughton MJ, Bower JK, Kuller L, Sarto GE, Stefanick ML, Van Horn L, Jackson RD, Paskett ED.

Cancer Epidemiol. 2017 Dec;51:62-67. doi: 10.1016/j.canep.2017.10.009. Epub 2017 Oct 16.

PMID:
29049937
10.

Cognitive appraisal of environmental stimuli induces emotion-like states in fish.

Cerqueira M, Millot S, Castanheira MF, Félix AS, Silva T, Oliveira GA, Oliveira CC, Martins CIM, Oliveira RF.

Sci Rep. 2017 Oct 13;7(1):13181. doi: 10.1038/s41598-017-13173-x.

11.

Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women's Health Study.

Felix AS, Blair CK, Lehman A, Bower JK, Raman SV, Lazovich D, Cohn DE, Prizment AE.

Cancer Causes Control. 2017 Oct;28(10):1043-1051. doi: 10.1007/s10552-017-0953-4. Epub 2017 Sep 1.

PMID:
28864924
12.

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251.

13.

Intentional Weight Loss and Endometrial Cancer Risk.

Luo J, Chlebowski RT, Hendryx M, Rohan T, Wactawski-Wende J, Thomson CA, Felix AS, Chen C, Barrington W, Coday M, Stefanick M, LeBlanc E, Margolis KL.

J Clin Oncol. 2017 Apr 10;35(11):1189-1193. doi: 10.1200/JCO.2016.70.5822. Epub 2017 Feb 6.

14.

Bokhman Redux: Endometrial cancer "types" in the 21st century.

Suarez AA, Felix AS, Cohn DE.

Gynecol Oncol. 2017 Feb;144(2):243-249. doi: 10.1016/j.ygyno.2016.12.010. Epub 2016 Dec 16.

PMID:
27993480
15.

Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.

Felix AS, Yang HP, Bell DW, Sherman ME.

Adv Exp Med Biol. 2017;943:3-46. Review.

PMID:
27910063
16.

High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.

Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME.

Int J Cancer. 2017 Feb 1;140(3):555-564. doi: 10.1002/ijc.30470. Epub 2016 Nov 14.

17.

Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis.

Felix AS, Lenz P, Pfeiffer RM, Hewitt SM, Morris J, Patel DA, Geller B, Vacek PM, Weaver DL, Chicoine RE, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn SD, Johnson JM, Cora RL, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2016 Aug 23;18(1):88. doi: 10.1186/s13058-016-0746-9.

18.

Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.

Brinton LA, Trabert B, Anderson GL, Falk RT, Felix AS, Fuhrman BJ, Gass ML, Kuller LH, Pfeiffer RM, Rohan TE, Strickler HD, Xu X, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1081-9. doi: 10.1158/1055-9965.EPI-16-0225. Epub 2016 Apr 12.

19.

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study.

Felix AS, Bunch K, Yang HP, Arem H, Trabert B, Gierach GL, Park Y, Lowery WJ, Brinton LA.

Gynecol Oncol Rep. 2015 May 8;13:13-7. doi: 10.1016/j.gore.2015.04.007. eCollection 2015 Aug.

20.

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.

Felix AS, Scott McMeekin D, Mutch D, Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe OB, Park KJ, Sherman ME, Brinton LA.

Gynecol Oncol. 2015 Oct;139(1):70-6. doi: 10.1016/j.ygyno.2015.08.022. Epub 2015 Sep 1.

21.

Structural and ultrastructural evaluation of the aortic wall after transplantation of bone marrow-derived cells (BMCs) in a model for atherosclerosis.

Felix AS, Monteiro N, Rocha VN, Oliveira G, Nascimento AL, de Carvalho L, Thole A, Carvalho J.

Biochem Cell Biol. 2015 Aug;93(4):367-75. doi: 10.1139/bcb-2015-0006. Epub 2015 May 4.

PMID:
26151357
22.

Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study.

Arem H, Park Y, Felix AS, Zervoudakis A, Brinton LA, Matthews CE, Gunter MJ.

Br J Cancer. 2015 Jul 28;113(3):562-8. doi: 10.1038/bjc.2015.224. Epub 2015 Jun 23.

23.

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Felix AS, Brinton LA, McMeekin DS, Creasman WT, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R, Sherman ME.

J Natl Cancer Inst. 2015 Jun 18;107(9). pii: djv158. doi: 10.1093/jnci/djv158. Print 2015 Sep.

24.

Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.

Felix AS, Arem H, Trabert B, Gierach GL, Park Y, Pfeiffer RM, Brinton LA.

Cancer Causes Control. 2015 Aug;26(8):1055-63. doi: 10.1007/s10552-015-0598-0. Epub 2015 May 12.

25.

Cell-cycle protein expression in a population-based study of ovarian and endometrial cancers.

Felix AS, Sherman ME, Hewitt SM, Gunja MZ, Yang HP, Cora RL, Boudreau V, Ylaya K, Lissowska J, Brinton LA, Wentzensen N.

Front Oncol. 2015 Feb 9;5:25. doi: 10.3389/fonc.2015.00025. eCollection 2015.

26.

Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).

Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, Cerhan JR, Clendenen TV, Felix AS, Friedenreich CM, Garcia-Closas M, Goodman MT, Liang X, Lissowska J, Lu L, Magliocco AM, McCann SE, Moysich KB, Olson SH, Petruzella S, Pike MC, Polidoro S, Ricceri F, Risch HA, Sacerdote C, Setiawan VW, Shu XO, Spurdle AB, Trabert B, Webb PM, Wentzensen N, Xiang YB, Xu Y, Yu H, Zeleniuch-Jacquotte A, Brinton LA.

Br J Cancer. 2015 Mar 3;112(5):925-33. doi: 10.1038/bjc.2015.24. Epub 2015 Feb 17.

27.

Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database.

Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):261-7. doi: 10.1158/1055-9965.EPI-14-0923.

28.

Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, Adami HO, Beresford S, Bernstein L, Chen C, Cook LS, De Vivo I, Doherty JA, Friedenreich CM, Gapstur SM, Hill D, Horn-Ross PL, Lacey JV, Levi F, Liang X, Lu L, Magliocco A, McCann SE, Negri E, Olson SH, Palmer JR, Patel AV, Petruzella S, Prescott J, Risch HA, Rosenberg L, Sherman ME, Spurdle AB, Webb PM, Wise LA, Xiang YB, Xu W, Yang HP, Yu H, Zeleniuch-Jacquotte A, Brinton LA.

Int J Cancer. 2015 Mar 1;136(5):E410-22. doi: 10.1002/ijc.29229. Epub 2014 Sep 30.

29.

Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.

Felix AS, Yang HP, Gierach GL, Park Y, Brinton LA.

Cancer Causes Control. 2014 Apr;25(4):479-89. doi: 10.1007/s10552-014-0350-1. Epub 2014 Feb 1.

30.

Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute.

Chawla N, Kepka DL, Heckman-Stoddard BM, Horne HN, Felix AS, Luhn P, Pelser C, Barkley J, Faupel-Badger JM.

J Oncol Pract. 2013 Nov;9(6):e284-9. doi: 10.1200/JOP.2013.001129. Epub 2013 Oct 1.

31.

Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial.

Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA.

Int J Cancer. 2014 Feb 15;134(4):954-60. doi: 10.1002/ijc.28404. Epub 2013 Aug 28.

32.

Menopausal hormone therapy and risk of endometrial cancer.

Brinton LA, Felix AS.

J Steroid Biochem Mol Biol. 2014 Jul;142:83-9. doi: 10.1016/j.jsbmb.2013.05.001. Epub 2013 May 13.

33.

Recent changes in endometrial cancer trends among menopausal-age U.S. women.

Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B.

Cancer Epidemiol. 2013 Aug;37(4):374-7. doi: 10.1016/j.canep.2013.03.008. Epub 2013 Apr 13.

34.

Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R.

Gynecol Oncol. 2013 May;129(2):277-84. doi: 10.1016/j.ygyno.2013.02.023. Epub 2013 Feb 26.

35.

Noninvasive measurement of steroid hormones in zebrafish holding-water.

Félix AS, Faustino AI, Cabral EM, Oliveira RF.

Zebrafish. 2013 Mar;10(1):110-5. doi: 10.1089/zeb.2012.0792. Epub 2013 Feb 27.

36.

The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.

Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Ou Shu X, van den Brandt PA, Virkus RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA.

Br J Cancer. 2013 Feb 19;108(3):727-34. doi: 10.1038/bjc.2013.2. Epub 2013 Jan 24.

37.

Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.

Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA.

Am J Epidemiol. 2013 Jan 15;177(2):142-51. doi: 10.1093/aje/kws200. Epub 2012 Nov 21.

38.

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.

Felix AS, Edwards RP, Stone RA, Chivukula M, Parwani AV, Bowser R, Linkov F, Weissfeld JL.

Br J Cancer. 2012 Jun 5;106(12):2004-9. doi: 10.1038/bjc.2012.200. Epub 2012 May 22.

39.

Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Linkov F, Maxwell GL, Felix AS, Lin Y, Lenzner D, Bovbjerg DH, Lokshin A, Hennon M, Jakicic JM, Goodpaster BH, DeLany JP.

Gynecol Oncol. 2012 Apr;125(1):114-9. doi: 10.1016/j.ygyno.2011.12.439. Epub 2011 Dec 22.

40.

Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.

Felix AS, Stone RA, Chivukula M, Bowser R, Parwani AV, Linkov F, Edwards RP, Weissfeld JL.

Int J Cancer. 2012 Jul 15;131(2):E114-21. doi: 10.1002/ijc.27317. Epub 2012 Jan 3.

41.

Carotid body remodelling in l-NAME-induced hypertension in the rat.

Felix AS, Rocha VN, Nascimento AL, de Carvalho JJ.

J Comp Pathol. 2012 May;146(4):348-56. doi: 10.1016/j.jcpa.2011.07.007. Epub 2011 Sep 6.

PMID:
21899859
42.

Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.

Felix AS, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, Linkov F.

Int J Gynecol Cancer. 2011 Jul;21(5):877-84. doi: 10.1097/IGC.0b013e31821a62dd.

43.

Racial disparities in risk of second primary cancers in endometrial cancer patients: Analysis of SEER Data.

Felix AS, Linkov F, Maxwell GL, Ragin C, Taioli E.

Int J Gynecol Cancer. 2011 Feb 1;21(2):309-315.

44.

Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer.

Felix AS, Edwards R, Bowser R, Linkov F.

Cancer Microenviron. 2010 Feb 26;3(1):49-56. doi: 10.1007/s12307-010-0042-7.

45.

Factors associated with Type I and Type II endometrial cancer.

Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, Linkov F.

Cancer Causes Control. 2010 Nov;21(11):1851-6. doi: 10.1007/s10552-010-9612-8. Epub 2010 Jul 14.

46.

Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.

Felix AS, Weissfeld J, Edwards R, Linkov F.

Eur J Gynaecol Oncol. 2010;31(2):139-44. Review.

47.

Cancer screening and cancer mortality in Nevis, West Indies.

Felix AS, Avery G, Mutetwa B, Ishmael R, Ragin C, Taioli E.

West Indian Med J. 2009 Sep;58(4):311-8.

PMID:
20099770
48.

International pooled analysis of cancer incidence in children after assisted reproductive technologies: interim report.

Felix AS, Bruinsma F, Klemetti R, Gissler M, Lerner-Geva L, Taioli E.

Future Oncol. 2009 Aug;5(6):901-6. doi: 10.2217/fon.09.54.

PMID:
19663738
49.

The changing patterns of bladder cancer in Egypt over the past 26 years.

Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML.

Cancer Causes Control. 2008 May;19(4):421-9. doi: 10.1007/s10552-007-9104-7. Epub 2008 Jan 10.

50.

Monitor-chemistry: antiretrovirals: the first [Foscarnet]-[TSAO-T] conjugates.

Félix AS.

Drug Discov Today. 2005 Mar 15;10(6):446. No abstract available.

PMID:
15808824

Supplemental Content

Loading ...
Support Center